Patent ID: 9238017
Filing Date: 2016-01-19
CPC Classification: A61K,A61P

Claim Text:
1. A method of mitigating the hepatotoxicity of a hepatotoxic compound, the method comprising: formulating a composition of the hepatotoxic compound by combining a quantity of the hepatotoxic compound with a quantity of nicotinamide, a quantity of methionine, and a quantity of folic acid into a single individual dosage form selected from the group consisting of a capsule, a tablet or an oral solution, and further administering the individual dosage form containing the hepatotoxic compound, nicotinamide, folic acid, and methionine to a patient in need of the hepatotoxic compound, wherein the hepatotoxic compound is selected from the group consisting of acetaminophen, atorvastatin, simvastatin, niacin, fluconazole, divalproex sodium, and valproic acid.